RE

Recro Pharma

- NASDAQ:REPH
Last Updated 2024-04-26

Shareholders Data

Shareholders
Ticker Symbol Entity Name Form Type Access Number Period As Of Date Filing Date Institution Name CIK Name of Issuer Title of Class CUSIP Value SHRS or PRN Amount SHRS or PRN Type PUT_CALL Investment Discretion Other Manager Voting Authority Sole Voting Authority Shared Voting Authority None Date Added Date Updated Company Name Sector Industry
nasdaq:reph nasdaq:reph Shareholders 13F-HR 0000201772-22-000002 Mar 31st, 2022 12:00AM May 9th, 2022 12:00AM May 9th, 2022 12:00AM ESSEX INVESTMENT MANAGEMENT CO LLC 201772 SOCIETAL CDMO INC COM COM 75629F109 1440 799841 SH SOLE 360020 0 439821 May 10th, 2022 01:24AM May 10th, 2022 01:24AM Recro Pharma Pharmaceuticals & Biotechnology
nasdaq:reph nasdaq:reph Shareholders 13F-HR 0000950123-22-000377 Dec 31st, 2021 12:00AM Jan 21st, 2022 12:00AM Jan 21st, 2022 12:00AM Russell Investments Group, Ltd. 1692234 Recro Pharma Inc Common Stock 75629F109 284 166333 SH SOLE 46 166333 0 0 May 6th, 2022 06:58AM May 6th, 2022 06:58AM Recro Pharma Pharmaceuticals & Biotechnology
nasdaq:reph nasdaq:reph Shareholders 13F-HR 0000950123-22-000377 Dec 31st, 2021 12:00AM Jan 21st, 2022 12:00AM Jan 21st, 2022 12:00AM Russell Investments Group, Ltd. 1692234 Recro Pharma Inc Common Stock 75629F109 439 257090 SH DFND 12 0 0 257090 May 6th, 2022 06:58AM May 6th, 2022 06:58AM Recro Pharma Pharmaceuticals & Biotechnology
nasdaq:reph nasdaq:reph Shareholders 13F-HR/A 0000769993-22-000005 Sep 30th, 2021 12:00AM Jan 20th, 2022 12:00AM Jan 20th, 2022 12:00AM GOLDMAN SACHS GROUP INC 886982 RECRO PHARMA INC CMN 75629F109 36 17364 SH DFND 2 17364 0 0 May 6th, 2022 06:52AM May 6th, 2022 06:52AM Recro Pharma Pharmaceuticals & Biotechnology
nasdaq:reph nasdaq:reph Shareholders 13F-HR/A 0000769993-22-000005 Sep 30th, 2021 12:00AM Jan 20th, 2022 12:00AM Jan 20th, 2022 12:00AM GOLDMAN SACHS GROUP INC 886982 RECRO PHARMA INC CMN 75629F109 61 29531 SH DFND 1 29506 0 25 May 6th, 2022 06:52AM May 6th, 2022 06:52AM Recro Pharma Pharmaceuticals & Biotechnology
nasdaq:reph nasdaq:reph Shareholders 13F-HR 0000950123-22-004585 Mar 31st, 2022 12:00AM May 5th, 2022 12:00AM May 5th, 2022 12:00AM Russell Investments Group, Ltd. 1692234 Societal CDMO Inc Common Stock 75629F109 78 43636 SH DFND 43636 0 0 May 6th, 2022 01:46AM May 6th, 2022 01:46AM Recro Pharma Pharmaceuticals & Biotechnology
nasdaq:reph nasdaq:reph Shareholders 13F-HR 0000950123-22-004585 Mar 31st, 2022 12:00AM May 5th, 2022 12:00AM May 5th, 2022 12:00AM Russell Investments Group, Ltd. 1692234 Societal CDMO Inc Common Stock 75629F109 802 445887 SH DFND 445887 0 0 May 6th, 2022 01:46AM May 6th, 2022 01:46AM Recro Pharma Pharmaceuticals & Biotechnology
nasdaq:reph nasdaq:reph Shareholders 13F-HR 0000950123-22-004585 Mar 31st, 2022 12:00AM May 5th, 2022 12:00AM May 5th, 2022 12:00AM Russell Investments Group, Ltd. 1692234 Societal CDMO Inc Common Stock 75629F109 202 112426 SH SOLE 42 112426 0 0 May 6th, 2022 01:46AM May 6th, 2022 01:46AM Recro Pharma Pharmaceuticals & Biotechnology
nasdaq:reph nasdaq:reph Shareholders 13F-HR 0000950123-22-004585 Mar 31st, 2022 12:00AM May 5th, 2022 12:00AM May 5th, 2022 12:00AM Russell Investments Group, Ltd. 1692234 Societal CDMO Inc Common Stock 75629F109 462 257090 SH DFND 12 0 0 257090 May 6th, 2022 01:46AM May 6th, 2022 01:46AM Recro Pharma Pharmaceuticals & Biotechnology
nasdaq:reph nasdaq:reph Shareholders 13F-HR/A 0000948046-21-000195 Sep 30th, 2018 12:00AM Dec 21st, 2021 12:00AM Dec 21st, 2021 12:00AM DEUTSCHE BANK AG\ 948046 RECRO PHARMA INC COM 75629F109 238 33443 SH DFND 33443 0 0 May 5th, 2022 07:59AM May 5th, 2022 07:59AM Recro Pharma Pharmaceuticals & Biotechnology

Request a demo to view additional historical data, and much more.

Make fast
queries

No longer rely on engineers to access data; build and share queries with intuitive tools, and derive insights in real time.

Bookmark queries with your team

Save and share custom queries using a private bookmarking feature, accessible to your whole team.

Be first to know with alerts

Scan data points across millions of companies and receive emails when relevant metrics cross critical thresholds.

Visualize data for quick insights

Create custom keyword-based word clouds, charts, and advanced visualizations to quickly analyze the data.

Map competitor locations

Analyze competitor presence and growth over time by overlaying store locations with the Nearby Competitor feature.

Add widgets to your dashboards

Access existing maps, charts, word clouds, and other visualizations to understand your data quickly. Or build custom widgets to view data just the way you want it.